DTC
OLMA icon

Deep Track Capital’s Olema Pharmaceuticals OLMA Stock Holding History

Deep Track Capital’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,470,172
Closed -$34M – 67
2025
Q3 		$34M Buy
3,470,172
+27,339
+0.8% +$164K 0.95% 31
2025
Q2 		$14.7M Hold
3,442,833
– – 0.47% 41
2025
Q1 		$12.9M Hold
3,442,833
– – 0.42% 47
2024
Q4 		$20.1M Sell
3,442,833
-557,167
-14% -$5.56M 0.75% 36
2024
Q3 		$47.8M Hold
4,000,000
– – 1.51% 23
2024
Q2 		$43.3M Buy
4,000,000
+774,581
+24% +$8.4M 1.29% 30
2024
Q1 		$36.5M Buy
3,225,419
+1,294,525
+67% +$16.7M 1.05% 38
2023
Q4 		$27.1M Hold
1,930,894
– – 0.9% 41
2023
Q3 		$23.8M Buy
+1,930,894
New +$19.7M 0.92% 33

Other funds holding OLMA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Deep Track Capital's OLMA Position: Q4 2025 in Review

Deep Track Capital sold out of Olema Pharmaceuticals (OLMA) in Q4 2025, closing a stake of 3,470,172 shares — an estimated $34M sold.

Deep Track Capital first reported a position in OLMA in Q3 2023 and held it in 9 quarters. The position peaked at $47.8M in Q3 2024. 200 funds tracked by Wall St. Rank hold OLMA as of Q4 2025.

  • Deep Track Capital reported no remaining Olema Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Deep Track Capital sold 3,470,172 Olema Pharmaceuticals shares in Q4 2025, an estimated $34M.
  • Deep Track Capital first reported a position in Olema Pharmaceuticals in Q3 2023 and held it in 9 quarters.
  • Deep Track Capital's Olema Pharmaceuticals position peaked at $47.8M in Q3 2024.
  • 200 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2025.

Based on Deep Track Capital's 13F filing for Q4 2025, filed 13 Feb 2026.